Skip to main content

Eli Lilly and Company statistics

  • LLY · NYSE
  • Pharmaceuticals
  • S&P 500
$1443.50+1.14%Close 13 Nov 2026 · Market value $1.37T

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Eli Lilly and Company is valued at $1.37T on its latest close. Its price is 49.6 times its earnings.

Market value$1.37T
Enterprise value$1.40T
Price / earnings49.57
Price / sales15.81
Price / book33.95
EV / EBITDA37.74
EV / sales16.22
Price / free cash flow69.54
Price / free cash flow, own 5-year average282.76
EV / EBIT40.35
EV / free cash flow71.81
Free cash flow yield1.4%
Dividend yield0.4%

Share price

Latest close$1443.50
Day's change+1.1%
52-week high$1460.00
52-week low$850.51
From 52-week high−1.1%
Return · 1 month+14.8%
Return · 3 months+16.0%
Return · year to date+34.3%
Return · 1 year+41.8%
Beta · 1 year against the S&P 5000.30
50-day average$1241.10
200-day average$1109.30
RSI 1469.7
Average volume · 20 sessions3.0M

Margins and returns

For fiscal 2025, as filed.

Gross margin83.0%
Operating margin40.9%
Net margin31.7%
Free cash flow margin13.8%
Return on equity101%
Return on assets22.3%
Return on invested capital34.4%
Return on invested capital, 5-year average22.3%
Return on capital employed41.7%
Stock-based compensation / revenue1.0%

Financial position

At the end of fiscal 2025.

Cash and equivalents$7.27B
Total debt$43.87B
Net debt$36.60B
Current ratio1.58
Quick ratio0.57
Debt / equity1.65
Net debt / EBITDA1.28
Interest coverage29.75

Growth

Revenue, latest quarter on a year+38.6%
Revenue, twelve months on a year+45.5%
EPS, latest quarter on a year+16.3%
EPS, twelve months on a year+50.7%
Revenue, 5-year compound+21.6%
Revenue, 10-year compound+12.6%
Net income, 5-year compound+27.2%
Free cash flow, 5-year compound+11.9%
EPS, 5-year compound+27.6%

Shares and dividends

For fiscal 2025, as filed.

Diluted shares899M
Shares outstanding, 5-year compound−0.3%
Net share repurchases$4.11B
Dividends per share$6.23
Dividend payout26.1%

Taxes

For fiscal 2025, as filed.

Income tax expense$5.09B
Effective tax rate19.8%

LLY in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.